Peru vs Sri Lanka: Death rate from cancer by sex
Peru
71.7 deaths per 100,000 people
in 2022
Sri Lanka
72.8 deaths per 100,000 people
in 2019
Peru rank
93rd
Sri Lanka rank
91st
Death rate from cancer by sex over time
- Peru
- Sri Lanka
How they compare
Sri Lanka currently reports 72.8 deaths per 100,000 people against 71.7 deaths per 100,000 people in Peru, a difference of 1.1 deaths per 100,000 people.
The two have swapped places 2 times across 20 shared years of data; in 1996 it was Peru ahead.
Peru ranks 93rd and Sri Lanka ranks 91st of 111 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Peru | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 83.36 deaths per 100,000 people | 47.04 deaths per 100,000 people | 36.32 deaths per 100,000 people | Peru |
| 2000s | 84.22 deaths per 100,000 people | 59.78 deaths per 100,000 people | 24.43 deaths per 100,000 people | Peru |
| 2010s | 77.36 deaths per 100,000 people | 71.82 deaths per 100,000 people | 5.54 deaths per 100,000 people | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer by sex, Peru or Sri Lanka?
- Sri Lanka, at 72.8 deaths per 100,000 people against 71.7 deaths per 100,000 people in Peru as of 2019.
- What is the difference in death rate from cancer by sex between Peru and Sri Lanka?
- 1.1 deaths per 100,000 people, with Sri Lanka ahead.
- How many years of comparable data are there for Peru and Sri Lanka?
- 20 years are reported by both, from 1996 to 2019.
- How do Peru and Sri Lanka rank globally for death rate from cancer by sex?
- Peru ranks 93rd and Sri Lanka ranks 91st of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Death rate from cancer by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms in males in those aged all ages per 100,000 people.